In vitro prediction and in vivo verification of enantioselective human tofisopam metabolite profilesCAMERON, Michael D; WRIGHT, Jason; BLACK, Christopher B et al.Drug metabolism and disposition. 2007, Vol 35, Num 10, pp 1894-1902, issn 0090-9556, 9 p.Article

Gas chromatography nitrogen phosphorous detection (GC-NPD) assay of tofisopam in human plasma for pharmacokinetic evaluationTOTH, Maria; BERECZKI, Andrea; DRABANT, Sandor et al.Journal of pharmaceutical and biomedical analysis. 2006, Vol 41, Num 4, pp 1354-1359, issn 0731-7085, 6 p.Article

Effet clinique du tofisopam sur le déséquilibre autonomeYOSHIKAWA, N.Yakuri to chiryo. 1989, Vol 17, Num 8, pp 4159-4172, issn 0386-3603Article

RECHERCHE DANS LA SERIE DES 5H-2,3-BENZODIAZEPINESKOROSI J; LANG T.1975; THERAP. HUNGAR.; HONGR.; DA. 1975; VOL. 23; NO 4; PP. 141-142; BIBL. 6 REF.Article

Arzneimittelanalysen mittels polarographischer Methoden. XXIV: Über das polarographische Verhalten des Tofisopam = Analyse de médicaments par polarographie. XXIV: comportement polarographique du tofisopam = Analysis of drugs by polarographic methods. XXIV: the polarographic behaviour of tofisopamOELSCHLÄGER, H; VOLKE, J; BRESCH, C et al.Archiv der Pharmazie (Weinheim). 1985, Vol 318, Num 3, pp 271-276, issn 0365-6233Article

Etude clinique de la grandaxine dans l'insuffisance vertebrobasilaireWATANABE, H.Yakuri to chiryo. 1987, Vol 15, Num 4, pp 285-290, issn 0386-3603Article

Method validation and determination of enantiomers and conformers in tofisopam drug substances and drug products by chiral high-performance liquid chromatography and kinetic and thermodynamic study of the interconversion of the conformersMOUGANG HU; PING HE; YONG CHEN et al.Journal of chromatography. 2006, Vol 1129, Num 1, pp 47-53, issn 0021-9673, 7 p.Article

Is tofisopam an atypical anxiolyticPELLOW, S; FILE, S. E.Neuroscience and biobehavioral reviews. 1986, Vol 10, Num 2, pp 221-227, issn 0149-7634Article

TRAITEMENT PAR TOFIZOPAM (GRANDAXINE) DES SYMPTOMES DE LA MENOPAUSECSILLAC M; GIMES R; KISS C et al.1975; THERAP. HUNGAR.; HONGR.; DA. 1975; VOL. 23; NO 4; PP. 176-181; BIBL. 28 REF.Article

Evaluation de la grandaxine en dermatologieONO, T; KITOH, M.Yakuri to chiryo. 1988, Vol 16, Num 8, pp 489-495, issn 0386-3603Article

DONNEES RELATIVES A LA PHARMACOCINETIQUE HUMAINE DE LA GRANDAXINERONAI S; OROSZ F; BOLLA K et al.1975; THERAP. HUNGAR.; HONGR.; DA. 1975; VOL. 23; NO 4; PP. 148-151; BIBL. 19 REF.Article

SUR LE TRAITEMENT DES ETATS PSYCHOPATHOLOGIQUES ASSOCIES A LA MYASTHENIE GRAVESZOBOR A.1975; THERAP. HUNGAR.; HONGR.; DA. 1975; VOL. 23; NO 4; PP. 170-175; BIBL. 17 REF.Article

A COMPARISON OF THE PSYCHOTROPIC PROFILES OF TOFISOPAM AND DIAZEPAMBOND A; LADER M.1982; EUR. J. CLIN. PHARMACOL.; ISSN 0031-6970; DEU; DA. 1982; VOL. 22; NO 2; PP. 137-142; BIBL. 17 REF.Article

Etude clinique du grandaxin 50® en chirurgie abdominaleOSUMI, K.Yakuri to chiryo. 1988, Vol 16, Num 2, pp 729-734, issn 0386-3603Article

Selective interaction of homophtalazine derivatives with morphineFEKETE, M. I. K; HORVATH, K; KEDVES, R et al.European journal of pharmacology. 1997, Vol 331, Num 2-3, pp 175-183, issn 0014-2999Article

New PDE4 inhibitors based on pharmacophoric similarity between papaverine and tofisopamBIHEL, Frederic J. J; JUSTINIANO, Hélène; SCHMITT, Martine et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 21, pp 6567-6572, issn 0960-894X, 6 p.Article

Effet du tofisopam (Grandaxin) sur le colon irritable et la névrose cardiaqueHANAJIMA, H.Yakuri to chiryo. 1987, Vol 15, Num 5, pp 307-317, issn 0386-3603Article

Etude clinique du grandaxin dans divers syndromes idiopathiquesKATO, A.Yakuri to chiryo. 1987, Vol 15, Num 8, pp 163-171, issn 0386-3603Article

EVALUATION CLINIQUE DE LA THERAPEUTIQUE PAR GRANDAXINE DES MALADES CONSULTANTS (A MULTICENTRIC STUDY)VARADY G; BOLLA K; SEBO J et al.1975; THERAP. HUNGAR.; HONGR.; DA. 1975; VOL. 23; NO 4; PP. 163-168; BIBL. 25 REF.Article

ACTION DU TOFISOPAM SUR LE NIVEAU DE VIGILANCE ERGONOMIQUE. SON INTERACTION AVEC LES EFFETS DE L'ALCOOL. ETUDE DE PHARMACOLOGIE CLINIQUEDEMANGE J; POIRIER JL.1980; PSYCHOL. MED.; FRA; DA. 1980; VOL. 12; NO 9; PP. 1993-2007; ABS. ENG; BIBL. 9 REF.Article

CARACTERISTIQUES PHARMACOLOGIQUES PRINCIPALES DE LA GRANDAXINE (TOFISOPAM EGYT-34)PETOCZ L; KOSACZKY I.1975; THERAP. HUNGAR.; HONGR.; DA. 1975; VOL. 23; NO 4; PP. 143-147; BIBL. 14 REF.Article

TOFIZOPAM AFFECTS BINDING OF (³H) MUSCIMOL TO GAMMA-AMINO-BUTYRIC ACID RECEPTORS IN RAT AND MOUSE BRAINSSAANO V.1982; PHARMACOLOGICAL RESEARCH COMMUNICATIONS; ISSN 0031-6989; GBR; DA. 1982; VOL. 14; NO 8; PP. 745-757; BIBL. 2 P.Article

UTILITE D'UN NOUVEL ANXIOLYTIQUE, LE TOFISOPAM DANS LA PRATIQUE GASTRO-ENTEROLOGIQUE COURANTE.RISTELHUEBER J.1977; REV. FR. GASTRO-ENTEROL.; FR.; DA. 1977; NO 125; PP. 49-52Article

Application of Drug Repositioning Strategy to TOFISOPAMBERNARD, P; DUFRESNE-FAVETTA, C; FAVETTA, P et al.Current medicinal chemistry. 2008, Vol 15, Num 30, pp 3196-3203, issn 0929-8673, 8 p.Article

TOFIZOPAM SELECTIVELY INCREASES THE AFFINITY OF BENZODIAZEPINE BINDING SITES FOR (³H) FLUNITRAZEPAM BUT NOT FOR BETA (³H) CARBOLINE-3-CARBOXYLIC ACID ETHYL ESTERSAANO V.1982; PHARMACOLOGICAL RESEARCH COMMUNICATIONS; ISSN 0031-6989; GBR; DA. 1982; VOL. 14; NO 10; PP. 971-981; BIBL. 2 P.Article